Citadel Advisors »

Nrx Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Nrx Pharmaceuticals shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Nrx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Nrx Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nrx Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $57k 23k 2.44

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Tesla Motors Call Option (TSLA)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
Broadcom Call Option (AVGO)
Advanced Micro Devices Call Option (AMD)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)

View all positions for Citadel Advisors

Top funds holding Nrx Pharmaceuticals

Vanguard Group
AdvisorShares Investments
Geode Capital Management
Susquehanna International
BlackRock
Citadel Advisors
Virtu Financial
State Street Corporation
One Wealth Management Investment & Advisory Services
Morgan Stanley
Royal Bank of Canada
Tower Research Capital
Bank of America Corporation
Wells Fargo & Company
Goss Wealth Management

View all funds holding Nrx Pharmaceuticals